Estrella Immunopharma Inc. (ESLA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.20
• Market Cap: $81.54M
• EPS: $-0.24
• 52-Week High: $3.15
• 52-Week Low: $0.73

Market Sentiment

Estrella Immunopharma Inc. currently has a Bullish sentiment score of 0.44.

About Estrella Immunopharma Inc.

Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company based in Emeryville, California, focused on pioneering T-cell therapies aimed at treating blood cancers and solid tumors. With a strong commitment to advancing innovative immunotherapy solutions, Estrella seeks to address critical unmet medical needs in oncology. The company’s cutting-edge research and development efforts position it as a key player in the evolving landscape of cancer treatment, with an emphasis on h...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Estrella Immunopharma Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ESLA pay dividends?

Estrella Immunopharma Inc. (ESLA) does not currently pay a regular dividend.

What is ESLA's market cap?

Estrella Immunopharma Inc. (ESLA) has a market capitalization of $81.54M with a current stock price of $1.20.